Home » Stocks » BGMD

BG Medicine, Inc. (BGMD)

Stock Price: $0.1460 USD -0.0040 (-2.67%)
Updated Feb 23, 2021 3:48 PM EST - Market closed
Market Cap 535,049
Revenue (ttm) 1.57M
Net Income (ttm) -6.96M
Shares Out 11.37M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 23
Last Price $0.1460
Previous Close $0.1500
Change ($) -0.0040
Change (%) -2.67%
Day's Open 0.1500
Day's Range 0.1230 - 0.1500
Day's Volume 5,512
52-Week Range 0.0115 - 0.19

News

There are no news available yet.

About BGMD

BG Medicine engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Feb 4, 2011
CEO
Paul Sohmer
Employees
5
Stock Exchange
OTCMKTS
Ticker Symbol
BGMD
Full Company Profile